SF-1 a key player in the development and differentiation of steroidogenic tissues

Nuclear Receptor

Volumn 1, Issue , 2003, Pages

  Val, Pierre ^a   Lefrançois Martinez, Anne Marie ^a   Veyssière, Georges ^a   Martinez, Antoine ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; STEROID; STEROIDOGENIC FACTOR 1;

ADRENAL GLAND MALFORMATION; CHOLESTEROL TRANSPORT; GENE CONTROL; GONADAL AGENESIS; HISTOGENESIS; HORMONE RESPONSE; HUMAN; HYPOPHYSIS; IN VIVO STUDY; KNOCKOUT MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SEX DETERMINATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 1942477149     PISSN: 14781336     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-1336-1-8     Document Type: Review

References (223)

1. Morohashi K, Honda S, Inomata Y, Handa H, Omura T: A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 1992, 267:17913-9.
2. Rice DA, Mouw AR, Bogerd AM, Parker KL: A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 1991, 5:1552-61.
3. Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T: Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993, 268:7494-502.
4. Lavorgna G, Karim FD, Thummel CS, Wu C: Potential role for a FTZ-F1 steroid receptor superfamily member in the control of Drosophila metamorphosis. Proc Natl Acad Sci U S A 1993, 90:3004-8.
5. Laudet V: Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J Mol Endocrinol 1997, 19:207-26.
6. De Mendonca RL, Bouton D, Bertin B, Escriva H, Noel C, Vanacker JM, Cornette J, Laudet V, Pierce RJ: A functionally conserved member of the FTZ-F1 nuclear receptor family from Schistosoma mansoni. Eur J Biochem 2002, 269:5700-11.
7. Kotomura N, Ninomiya Y, Umesono K, Niwa O: Transcriptional regulation by competition between ELP isoforms and nuclear receptors. Biochem Biophys Res Commun 1997, 230:407-12.
8. Ninomiya Y, Okada M, Kotomura N, Suzuki K, Tsukiyama T, Niwa O: Genomic organization and isoforms of the mouse ELP gene. J Biochem (Tokyo) 1995, 118:380-9.
9. Luo X, Ikeda Y, Schlosser DA, Parker KL: Steroidogenic factor 1 is the essential transcript of the mouse Ftz-F1 gene. Mol Endocrinol 1995, 9:1233-9.
10. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al.: The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-9.
11. Hammer GD, Ingraham HA: Steroidogenic factor-1: its role in endocrine organ development and differentiation. Front Neuroendocrinol 1999, 20:199-223.
12. Wilson TE, Fahrner TJ, Milbrandt J: The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 1993, 13:5794-804.
13. Nitta M, Ku S, Brown C, Okamoto AY, Shan B: CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene. Proc Natl Acad Sci U S A 1999, 96:6660-5.
14. Li LA, Chiang EF, Chen JC, Hsu NC, Chen YJ, Chung BC: Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. Mol Endocrinol 1999, 13:1588-98.
15. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B, Jameson JL: Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 2002, 87:1829-33.
16. Mellon SH, Bair SR: 25-Hydroxycholesterol is not a ligand for the orphan nuclear receptor steroidogenic factor-1 (SF-1). Endocrinology 1998, 139:3026-9.
17. Giguere V: Orphan nuclear receptors: from gene to function. Endocr Rev 1999, 20:689-725.
18. Desclozeaux M, Krylova IN, Horn F, Fletterick RJ, Ingraham HA: Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol Cell Biol 2002, 22:7193-203.
19. Ito M, Yu RN, Jameson JL: Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol Endocrinol 1998, 12:290-301.
20. Crawford PA, Polish JA, Ganpule G, Sadovsky Y: The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. Mol Endocrinol 1997, 11:1626-35.
21. Li LA, Lala D, Chung BC: Function of steroidogenic factor 1 (SF1) ligand-binding domain in gene activation and interaction with AP1. Biochem Biophys Res Commun 1998, 250:318-20.
22. Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA: Interdomain communication regulating ligand binding by PPAR-gamma. Nature 1998, 396:377-80.
23. He B, Wilson EM: The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor. Mol Genet Metab 2002, 75:293-8.
24. He B, Bowen NT, Minges JT, Wilson EM: Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2. J Biol Chem 2001, 276:42293-301.
25. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HA: Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 1999, 3:521-6.
26. Ikeda Y, Shen WH, Ingraham HA, Parker KL: Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 1994, 8:654-62.
27. Hatano O, Takayama K, Imai T, Waterman MR, Takakusu A, Omura T, Morohashi K: Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 1994, 120:2787-97.
28. Hatano O, Takakusu A, Nomura M, Morohashi K: Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996, 1:663-71.
29. Sadovsky Y, Crawford PA, Woodson KG, Polish JA, Clements MA, Tourtellotte LM, Simburger K, Milbrandt J: Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc Natl Acad Sci U S A 1995, 92:10939-43.
30. Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL: Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 1993, 7:852-60.
31. Ramayya MS, Zhou J, Kino T, Segars JH, Bondy CA, Chrousos GP: Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J Clin Endocrinol Metab 1997, 82:1799-806.
32. Ben-Zimra M, Koler M, Orly J: Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element. Mol Endocrinol 2002, 16:1864-80.
33. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, Abbud R, Nilson JH, Parker KL: The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994, 8:2302-12.
34. Shinoda K, Lei H, Yoshii H, Nomura M, Nagano M, Shiba H, Sasaki H, Osawa Y, Ninomiya Y, Niwa O, et al.: Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 1995, 204:22-9.
35. Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL: The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 1995, 9:478-86.
36. Patel MV, McKay IA, Burrin JM: Transcriptional regulators of steroidogenesis, DAX-1 and SF-1, are expressed in human skin. J Invest Dermatol 2001, 117:1559-65.
37. Courchay G, Boyera N, Bernard BA, Mahe Y: Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacol 1996, 9:169-76.
38. Slominski A, Ermak G, Mihm M: ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab 1996, 81:2746-9.
39. Venencie PY, Meduri G, Pissard S, Jolivet A, Loosfelt H, Milgrom E, Misrahi M: Luteinizing hormone/human chorionic gonadotrophin receptors in various epidermal structures. Br J Dermatol 1999, 141:438-46.
40. Morohashi K, Tsuboi-Asai H, Matsushita S, Suda M, Nakashima M, Sasano H, Hataba Y, Li CL, Fukata J, Irie J, et al.: Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse. Blood 1999, 93:1586-94.
41. Wotus C, Levay-Young BK, Rogers LM, Gomez-Sanchez CE, Engeland WC: Development of adrenal zonation in fetal rats defined by expression of aldosterone synthase and 11b-hydroxylase. Endocrinology 1998, 139:4397-4403.
42. Martinez A, Val P, Sahut-Barnola I, Aigueperse C, Veyssiere G, Lefrancois Martinez AM: SF-1 controls the aldose reductase akr1b7 gene promoter in transgenic mice through an atypical binding site. Endocrinology 2003, 144:2111-2120.
43. Okimoto DK, Blaus A, Schmidt M, Gordon MK, Dent GW, Levine S: Differential expression of c-fos and tyrosine hydroxylase mRNA in the adrenal gland of the infant rat: evidence for an adrenal hyporesponsive period. Endocrinology 2002, 143:1717-25.
44. Hanley NA, Ball SG, Clement-Jones M, Hagan DM, Strachan T, Lindsay S, Robson S, Ostrer H, Parker KL, Wilson DI: Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev 1999, 87:175-80.
45. de Santa Barbara P, Moniot B, Poulat F, Berta P: Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev Dyn 2000, 217:293-8.
46. Mesiano S, Jaffe RB: Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 1997, 62:62-72.
47. Hanley NA, Rainey WE, Wilson DI, Ball SG, Parker KL: Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol Endocrinol 2001, 15:57-68.
48. Roselli CE, Jorgensen EZ, Doyle MW, Ronnekleiv OK: Expression of the orphan receptor steroidogenic factor-1 mRNA in the rat medial basal hypothalamus. Brain Res Mol Brain Res 1997, 44:66-72.
49. Stallings NR, Hanley NA, Majdic G, Zhao L, Bakke M, Parker KL: Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1. Endocr Res 2002, 28:497-504.
50. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-90.
51. Dellovade TL, Young M, Ross EP, Henderson R, Caron K, Parker K, Tobet SA: Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J Comp Neurol 2000, 423:579-89.
52. Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, Dobbins RL, McGarry JD, Parker KL: Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 2002, 143:607-14.
53. Zhao L, Bakke M, Krimkevich Y, Cushman LJ, Parlow AF, Camper SA, Parker KL: Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. Development 2001, 128:147-54.
54. Zhao L, Bakke M, Parker KL: Pituitary-specific knockout of steroidogenic factor 1. Mol Cell Endocrinol 2001, 185:27-32.
55. Zhao L, Bakke M, Krimkevich Y, Cushman LJ, Parlow AF, Camper SA, Parker KL: Hypomorphic phenotype in mice with pituitary-specific knockout of steroidogenic factor 1. Genesis 2001, 30:65-9.
56. Barnhart KM, Mellon PL: The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 1994, 8:878-85.
57. Halvorson LM, Kaiser UB, Chin WW: Stimulation of luteinizing hormone beta gene promoter activity by the orphan nuclear receptor, steroidogenic factor-1. J Biol Chem 1996, 271:6645-50.
58. Keri RA, Nilson JH: A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone beta subunit promoter in gonadotropes of transgenic mice. J Biol Chem 1996, 271:10782-5.
59. Brown P, McNeilly AS: Steroidogenic factor-1 (SF-1) and the regulation of expression of luteinising hormone and follicle stimulating hormone b-subunits in the sheep anterior pituitary in vivo. Int J Biochem Cell Biol 1997, 29:1513-24.
60. Levallet J, Koskimies P, Rahman N, Huhtaniemi I: The promoter of murine follicle-stimulating hormone receptor: functional characterization and regulation by transcription factor steroidogenic factor 1. Mol Endocrinol 2001, 15:80-92.
61. Pincas H, Laverriere JN, Counis R: Pituitary adenylate cyclase-activating polypeptide and cyclic adenosine 3′,5′-monophosphate stimulate the promoter activity of the rat gonadotropin-releasing hormone receptor gene via a bipartite response element in gonadotrope-derived cells. J Biol Chem 2001, 276:23562-71.
62. Pincas H, Amoyel K, Counis R, Laverriere JN: Proximal cis-acting elements, including steroidogenic factor 1, mediate the efficiency of a distal enhancer in the promoter of the rat gonadotropin-releasing hormone receptor gene. Mol Endocrinol 2001, 15:319-37.
63. Ngan ES, Cheng PK, Leung PC, Chow BK: Steroidogenic factor-1 interacts with a gonadotrope-specific element within the first exon of the human gonadotropin-releasing hormone receptor gene to mediate gonadotrope-specific expression. Endocrinology 1999, 140:2452-62.
64. Kendall SK, Saunders TL, Jin L, Lloyd RV, Glode LM, Nett TM, Keri RA, Nilson JH, Camper SA: Targeted ablation of pituitary gonadotropes in transgenic mice. Mol Endocrinol 1991, 5:2025-36.
65. Brobeck JR: Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol Rev 1946, 26:541-559.
66. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, et al.: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001, 412:877-84.
67. Achermann JC, Ito M, Hindmarsh PC, Jameson JL: A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999, 22:125-6.
68. Biason-Lauber A, Schoenle EJ: Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000, 67:1563-8.
69. Bland ML, Jamieson CA, Akana SF, Bornstein SR, Eisenhofer G, Dallman MF, Ingraham HA: Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci U S A 2000, 97:14488-93.
70. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000, 6:507-15.
71. Wang ZN, Bassett M, Rainey WE: Liver receptor homologue-1 is expressed in the adrenal and can regulate transcription of 11 beta-hydroxylase. J Mol Endocrinol 2001, 27:255-8.
72. Falender AE, Lanz R, Malenfant D, Belanger L, Richards JS: Differential expression of steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary. Endocrinology 2003, 144:3598-3610.
73. Sirianni R, Seely JB, Attia G, Stocco DM, Carr BR, Pezzi V, Rainey WE: Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J Endocrinol 2002, 174:R13-7.
74. Crawford PA, Sadovsky Y, Milbrandt J: Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage. Mol Cell Biol 1997, 17:3997-4006.
75. Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, Hammer GD: Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 2002, 143:3122-35.
76. Bicknell AB, Lomthaisong K, Woods RJ, Hutchinson EG, Bennett HP, Gladwell RT, Lowry PJ: Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 2001, 105:903-12.
77. Kelman Z: PCNA: structure, functions and interactions. Oncogene 1997, 14:629-40.
78. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE: Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 2002, 28:125-35.
79. Hu MC, Hsu NC, Pai CI, Wang CK, Chung B: Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol Endocrinol 2001, 15:812-8.
80. Gizard F, El-Alfy M, Duguay Y, Lavallee B, DeWitte F, Staels B, Beatty BG, Hum DW: Function of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expression. Endocr Res 2002, 28:559-74.
81. Wang XL, Bassett M, Zhang Y, Yin S, Clyne C, White PC, Rainey WE: Transcriptional regulation of human 11beta-hydroxylase (hCYP11B1). Endocrinology 2000, 141:3587-94.
82. Sewer MB, Waterman MR: Transcriptional complexes at the CYP17 CRS. Endocr Res 2002, 28:551-8.
83. Jacob AL, Lund J: Mutations in the activation function-2 core domain of steroidogenic factor-1 dominantly suppresses PKA-dependent transactivation of the bovine CYP17 gene. J Biol Chem 1998, 273:13391-4.
84. Bakke M, Lund J: Mutually exclusive interactions of two nuclear orphan receptors determine activity of a cyclic adenosine 3′,5′-monophosphate-responsive sequence in the bovine CYP17 gene. Mol Endocrinol 1995, 9:327-39.
85. Michael MD, Kilgore MW, Morohashi K, Simpson ER: Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem 1995, 270:13561-6.
86. Carlone DL, Richards JS: Functional interactions, phosphorylation, and levels of 3′,5′-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells. Mol Endocrinol 1997, 11:292-304.
87. Pfeifer SM, Furth EE, Ohba T, Chang YJ, Rennert H, Sakuragi N, Billheimer JT, Strauss 3rd JF: Sterol carrier protein 2: a role in steroid hormone synthesis? J Steroid Biochem Mol Biol 1993, 47:167-72.
88. Stocco DM: Intramitochondrial cholesterol transfer. Biochim Biophys Acta 2000, 1486:184-97.
89. Mascaro C, Nadal A, Hegardt FG, Marrero PF, Haro D: Contribution of steroidogenic factor 1 to the regulation of cholesterol synthesis. Biochem J 2000, 350(Pt 3):785-90.
90. Martinez A, Val P, Jean C, Veyssiere G, Lefrancois-Martinez AM: SF-1 controls the expression of the scavenger gene akr1b7: in vitro and in vivo approaches. Endocr Res 2002, 28:515-8.
91. Val P, Aigueperse C, Lefrancois-Martinez AM, Jean C, Veyssiere G, Martinez A: Role of three SF-1 binding sites in the expression of the mvdp/akr1-b7 isocaproaldehyde reductase in Y1 cells. Endocr Res 2002, 28:527-33.
92. Aigueperse C, Val P, Pacot C, Darne C, Lalli E, P Sassone-Corsi, Veyssiere G, Jean C, Martinez A: SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells. Mol Endocrinol 2001, 15:93-111.
93. Lefrancois-Martinez AM, Tournaire C, Martinez A, Berger M, Daoudal S, Tritsch D, Veyssiere G, Jean C: Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells. J Biol Chem 1999, 274:32875-80.
94. Chinn AM, Ciais D, Bailly S, Chambaz E, LaMarre J, Feige JJ: Identification of two novel ACTH-responsive genes encoding manganese-dependent superoxide dismutase (SOD2) and the zinc finger protein TIS11b [tetradecanoyl phorbol acetate (TPA)-inducible sequence 11b]. Mol Endocrinol 2002, 16:1417-27.
95. McCann SM, Haens G, Mastronardi C, Walczewska A, Karanth S, Rettori V, Yu WH: The Role of Nitric Oxide (NO) in Control of LHRH Release that Mediates Gonadotropin Release and Sexual Behavior. Curr Pharm Des 2003, 9:381-90.
96. Wei X, Sasaki M, Huang H, Dawson VL, Dawson TM: The orphan nuclear receptor, steroidogenic factor 1, regulates neuronal nitric oxide synthase gene expression in pituitary gonadotropes. Mol Endocrinol 2002, 16:2828-39.
97. Ando H, Hew CL, Urano A: Signal transduction pathways and transcription factors involved in the gonadotropin-releasing hormone-stimulated gonadotropin subunit gene expression. Comp Biochem Physiol B Biochem Mol Biol 2001, 129:525-32.
98. Swain A, Lovell-Badge R: Mammalian sex determination: a molecular drama. Genes Dev 1999, 13:755-67.
99. Albrecht KH, Eicher EM: Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev Biol 2001, 240:92-107.
100. Swain A, Lovell-Badge R: Sex determination and differentiation. In: Mouse Development(Edited by: Janet R, Patrick T). 2002, 17:371-393.
101. de Santa Barbara P, Mejean C, Moniot B, Malcles MH, Berta P, Boizet-Bonhoure B: Steroidogenic factor-1 contributes to the cyclic-adenosine monophosphate down-regulation of human SRY gene expression. Biol Reprod 2001, 64:775-83.
102. Pilon N, Daneau I, Paradis V, Hamel F, Lussier JG, Viger RS, Silversides DW: Porcine SRY Promoter Is a Target for Steroidogenic Factor 1. Biol Reprod 2003, 68:1098-106.
103. Capel B: Sex in the 90s: SRY and the switch to the male pathway. Annu Rev Physiol 1998, 60:497-523.
104. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA: Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 1994, 77:651-61.
105. De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, Sudbeck P, Scherer G, Poulat F, Berta P: Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 1998, 18:6653-65.
106. Tremblay JJ, Viger RS: Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol Endocrinol 1999, 13:1388-401.
107. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA: Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998, 93:445-54.
108. Arango NA, Lovell-Badge R, Behringer RR: Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999, 99:409-19.
109. Zimmermann S, Schwarzler A, Buth S, Engel W, Adham IM: Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor-1. Mol Endocrinol 1998, 12:706-13.
110. Koskimies P, Levallet J, Sipila P, Huhtaniemi I, Poutanen M: Murine relaxin-like factor promoter: functional characterization and regulation by transcription factors steroidogenic factor 1 and DAX-1. Endocrinology 2002, 143:909-19.
111. Amsterdam A, Tajima K, Sasson R: Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 2002, 64:843-50.
112. Reinhart AJ, Williams SC, Clark BJ, Stocco DM: SF-1 (steroidogenic factor-1) and C/EBP beta (CCAAT/enhancer binding protein-beta) cooperate to regulate the murine StAR (steroidogenic acute regulatory) promoter. Mol Endocrinol 1999, 13:729-41.
113. Hasegawa T, Zhao L, Caron KM, Majdic G, Suzuki T, Shizawa S, Sasano H, Parker KL: Developmental roles of the steroidogenic acute regulatory protein (StAR) as revealed by StAR knockout mice. Mol Endocrinol 2000, 14:1462-71.
114. Hu MC, Hsu NC, El Hadj NB, Pai C, Chu HP, Wang CK, Chung BC: Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol Endocrinol 2002, 16:1943-50.
115. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U: Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999, 5:1066-70.
116. Bicknell AB, Lowry PJ: Adrenal growth is controlled by expression of specific pro-opiomelanocortin serine protease in the outer adrenal cortex. Endocr Res 2002, 28:589-95.
117. Pignatelli D, Ferreira J, Vendeira P, Magalhaes MC, Vinson GP: Proliferation of capsular stem cells induced by ACTH in the rat adrenal cortex. Endocr Res 2002, 28:683-91.
118. Bicknell AB: Identification of a receptor for N-POMC peptides. Endocr Res 2002, 28:309-14.
119. Lala DS, Syka PM, Lazarchik SB, Mangelsdorf DJ, Parker KL, Heyman RA: Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci U S A 1997, 94:4895-900.
120. Woodson KG, Crawford PA, Sadovsky Y, Milbrandt J: Characterization of the promoter of SF-1, an orphan nuclear receptor required for adrenal and gonadal development. Mol Endocrinol 1997, 11:117-26.
121. Scherrer SP, Rice DA, Heckert LL: Expression of steroidogenic factor 1 in the testis requires an interactive array of elements within its proximal promoter. Biol Reprod 2002, 67:1509-21.
122. Nomura M, Bartsch S, Nawata H, Omura T, Morohashi K: An E box element is required for the expression of the ad4bp gene, a mammalian homologue of ftz-f1 gene, which is essential for adrenal and gonadal development. J Biol Chem 1995, 270:7453-61.
123. Harris AN, Mellon PL: The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells. Mol Endocrinol 1998, 12:714-26.
124. Oba K, Yanase T, Ichino I, Goto K, Takayanagi R, Nawata H: Transcriptional regulation of the human FTZ-F1 gene encoding Ad4BP/SF-1. J Biochem (Tokyo) 2000, 128:517-28.
125. Nomura M, Nawata H, Morohashi K: Autoregulatory loop in the regulation of the mammalian ftz-f1 gene. J Biol Chem 1996, 271:8243-9.
126. Zubair M, Oka S, Ishihara S, Morohashi K: Analysis of Ad4BP/SF-1 gene regulatory region. Endocr Res 2002, 28:535.
127. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, Rossant J: The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999, 126:5771-83.
128. Tamura M, Kanno Y, Chuma S, Saito T, Nakatsuji N: Pod-1/Capsulin shows a sex- and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP/SF-1. Mech Dev 2001, 102:135-44.
129. Kent J, Wheatley SC, Andrews JE, Sinclair AH, Koopman P: A male-specific role for SOX9 in vertebrate sex determination. Development 1996, 122:2813-22.
130. Shen JH, Ingraham HA: Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. Mol Endocrinol 2002, 16:529-40.
131. Viger RS, Mertineit C, Trasler JM, Nemer M: Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Mullerian inhibiting substance promoter. Development 1998, 125:2665-75.
132. Tremblay JJ, Viger RS: GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 2001, 142:977-86.
133. Nomura M, Kawabe K, Matsushita S, Oka S, Hatano O, Harada N, Nawata H, Morohashi K: Adrenocortical and gonadal expression of the mammalian Ftz-F1 gene encoding Ad4BP/SF-1 is independent of pituitary control. J Biochem (Tokyo) 1998, 124:217-24.
134. Crawford PA, Sadovsky Y, Woodson K, Lee SL, Milbrandt J: Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol 1995, 15:4331-16.
135. P Zhang, Mellon SH: The orphan nuclear receptor steroidogenic factor-1 regulates the cyclic adenosine 3′,5′ -monophosphate-mediated transcriptional activation of rat cytochrome P450c17 (17 alpha-hydroxylase/c17-20 lyase). Mol Endocrinol 1996, 10:147-58.
136. Mamluk R, Greber Y, Meidan R: Hormonal regulation of messenger ribonucleic acid expression for steroidogenic factor-1, steroidogenic acute regulatory protein, and cytochrome P450 side-chain cleavage in bovine luteal cells. Biol Reprod 1999, 60:628-34.
137. Aesoy R, Mellgren G, Morohashi K, Lund J: Activation of cAMP-dependent protein kinase increases the protein level of steroidogenic factor-1. Endocrinology 2002, 143:295-303.
138. Chau YM, Crawford PA, Woodson KG, Polish JA, Olson LM, Sadovsky Y: Role of steroidogenic-factor 1 in basal and 3′,5′ -cyclic adenosine monophosphate-mediated regulation of cytochrome P450 side-chain cleavage enzyme in the mouse. Biol Reprod 1997, 57:765-71.
139. Enyeart JJ, Boyd RT, Enyeart JA: ACTH and AII differentially stimulate steroid hormone orphan receptor mRNAs in adrenal cortical cells. Mol Cell Endocrinol 1996, 124:97-110.
140. Hosokawa K, Dantes A, C Schere-Levy, Barash A, Yoshida Y, Kotsuji F, Vlodavsky I, Amsterdam A: Induction of Ad4BP/SF-1, steroidogenic acute regulatory protein, and cytochrome P450scc enzyme system expression in newly established human granulosa cell lines. Endocrinology 1998, 139:4679-87.
141. Sahut-Barnola I, Lefrancois-Martinez AM, Jean C, Veyssiere G, Martinez A: Adrenal tumorigenesis targeted by the corticotropin-regulated promoter of the aldo-keto reductase AKR1B7 gene in transgenic mice. Endocr Res 2000, 26:885-98.
142. Sugawara T, Abe S, Sakuragi N, Fujimoto Y, Nomura E, Fujieda K, Saito M, Fujimoto S: RIP 140 modulates transcription of the steroidogenic acute regulatory protein gene through interactions with both SF-1 and DAX-1. Endocrinology 2001, 142:3570-7.
143. Zhou D, Quach KM, Yang C, Lee SY, Pohajdak B, Chen S: PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1). Mol Endocrinol 2000, 14:986-98.
144. Zhou D, Chen S: PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif. Nucleic Acids Res 2001, 29:3939-48.
145. Kabe Y, Goto M, Shima D, Imai T, Wada T, Morohashi K, Shirakawa M, Hirose S, Handa H: The role of human MBF1 as a transcriptional coactivator. J Biol Chem 1999, 274:34196-202.
146. Borud B, Hoang T, Bakke M, Jacob AL, Lund J, Mellgren G: The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol Endocrinol 2002, 16:757-73.
147. Jacob AL, Lund J, Martinez P, Hedin L: Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J Biol Chem 2001, 276:37659-64.
148. Yan X, Mouillet JF, Ou Q, Sadovsky Y: A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity. Mol Cell Biol 2003, 23:414-23.
149. Ou Q, Mouillet JF, Yan X, Dorn C, Crawford PA, Sadovsky Y: The DEAD box protein DP103 is a regulator of steroidogenic factor-1. Mol Endocrinol 2001, 15:69-79.
150. Watanabe K, Clarke TR, Lane AH, Wang X, Donahoe PK: Endogenous expression of Mullerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proc Natl Acad Sci U S A 2000, 97:1624-9.
151. Ito M, Yu R, Jameson JL: DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997, 17:1476-83.
152. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J: Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998, 18:2949-56.
153. Liu Z, Simpson ER: Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression. Mol Cell Endocrinol 1999, 153:183-96.
154. Jorgensen JS, Nilson JH: AR suppresses transcription of the LHbeta subunit by interacting with steroidogenic factor-1. Mol Endocrinol 2001, 15:1505-16.
155. Halvorson LM, Ito M, Jameson JL, Chin WW: Steroidogenic factor-1 and early growth response protein 1 act through two composite DNA binding sites to regulate luteinizing hormone beta-subunit gene expression. J Biol Chem 1998, 273:14712-20.
156. Tremblay JJ, Drouin J: Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription. Mol Cell Biol 1999, 19:2567-76.
157. Kaiser UB, Halvorson LM, Chen MT: Sp1, steroidogenic factor 1 (SF-1), and early growth response protein 1 (egr-1) binding sites form a tripartite gonadotropin-releasing hormone response element in the rat luteinizing hormone-beta gene promoter: an integral role for SF-1. Mol Endocrinol 2000, 14:1235-45.
158. Tremblay JJ, Lanctot C, Drouin J: The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol 1998, 12:428-41.
159. Tremblay JJ, Marcil A, Gauthier Y, Drouin J: Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain. Embo J 1999, 18:3431-41.
160. Gizard F, Lavallee B, DeWitte F, Teissier E, Staels B, Hum DW: The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells. J Biol Chem 2002, 277:39144-55.
161. Gizard F, Lavallee B, DeWitte F, Hum DW: A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression. J Biol Chem 2001, 276:33881-33892.
162. Liu Z, Simpson ER: Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells. Mol Endocrinol 1997, 11:127-37.
163. Ito M, Park Y, Weck J, Mayo KE, Jameson JL: Synergistic activation of the inhibin alpha-promoter by steroidogenic factor-1 and cyclic adenosine 3′,5′-monophosphate. Mol Endocrinol 2000, 14:66-81.
164. Carlone DL, Richards JS: Evidence that functional interactions of CREB and SF-1 mediate hormone regulated expression of the aromatase gene in granulosa cells and constitutive expression in R2C cells. J Steroid Biochem Mol Biol 1997, 61:223-31.
165. Chan HM, La Thangue NB: p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Science 2001, 114:2363-2373.
166. Muscatelli F, Strom TM, Walker AP, Zanaria E, Recan D, Meindl A, Bardoni B, Guioli S, Zehetner G, Rabl W, et al.: Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994, 372:672-6.
167. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ER, et al.: An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994, 372:635-41.
168. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G, Ferrante E, Chiumello G, McCabe ER, Fraccaro M, et al.: A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994, 7:497-501.
169. Zanaria E, Bardoni B, Dabovic B, Calvari V, Fraccaro M, Zuffardi O, Camerino G: Xp duplications and sex reversal. Philos Trans R Soc Lond B Biol Sci 1995, 350:291-6.
170. Swain A, Narvaez V, Burgoyne P, Camerino G, Lovell-Badge R: Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998, 391:761-7.
171. Achermann JC, Meeks JJ, Jameson JL: Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol 2001, 185:17-25.
172. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G: Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996, 12:404-9.
173. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, Lalli E, Tamai KT, Sassone-Corsi P, Lovell-Badge R, Camerino G, et al.: Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol 1996, 10:1261-72.
174. Lalli E, Bardoni B, Zazopoulos E, Wurtz JM, Strom TM, Moras D, Sassone-Corsi P: A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol 1997, 11:1950-60.
175. Lalli E, Melner MH, Stocco DM, Sassone-Corsi P: DAX-1 blocks steroid production at multiple levels. Endocrinology 1998, 139:4237-43.
176. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P: DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997, 390:311-315.
177. Suzuki T, Kasahara M, Yoshioka H, Umesono K, Morohashi K: LXXLL motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Endocr Res 2002, 28:537.
178. Altincicek B, Tenbaum SP, Dressel U, Thormeyer D, Renkawitz R, Baniahmad A: Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem 2000, 275:7662-7.
179. Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL: Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998, 20:353-7.
180. Babu PS, Bavers DL, Beuschlein F, Shah S, Jeffs B, Jameson JL, Hammer GD: Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002, 143:665-73.
181. Richards JS: New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 2001, 15:209-18.
182. Gyles SL, Burns CJ, Whitehouse BJ, Sugden D, Marsh PJ, Persaud SJ, Jones PM: ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene. J Biol Chem 2001, 276:34888-95.
183. Sewer MB, Waterman MR: Adrenocorticotropin/cyclic adenosine 3′,5′-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase activity. Endocrinology 2002, 143:1769-77.
184. Jones PM, Sayed SB, Persaud SJ, Burns CJ, Gyles S, Whitehouse BJ: Cyclic AMP-induced expression of steroidogenic acute regulatory protein is dependent upon phosphoprotein phosphatase activites. J Mol Endocrinol 2000, 24:233-239.
185. Sewer MB, Waterman MR: cAMP-dependent protein kinase (PKA) enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J Biol Chem 2002, 27:27.
186. Fu M, Wang C, Wang J, Zhang X, Sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua SA, Jaffray E, et al.: Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol 2002, 22:3373-3388.
187. Hoyle C, Narvaez V, Alldus G, R Lovell-Badge, Swain A: Dax1 expression is dependent on steroidogenic factor 1 in the developing gonad. Mol Endocrinol 2002, 16:747-56.
188. Clemens JW, Lala DS, Parker KL, Richards JS: Steroidogenic factor-1 binding and transcriptional activity of the cholesterol side-chain cleavage promoter in rat granulosa cells. Endocrinology 1994, 134:1499-508.
189. Leers-Sucheta S, Morohashi K, Mason JI, Melner MH: Synergistic activation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase promoter by the transcription factor steroidogenic factor-1/adrenal 4-binding protein and phorbol ester. J Biol Chem 1997, 272:7960-7.
190. Tee MK, Babalola GO, Aza-Blanc P, Speek M, Gitelman SE, Miller WL: A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA: location of a cryptic CYP21 promoter element? Hum Mol Genet 1995, 4:2109-16.
191. Takayama K, Morohashi K, Honda S, Hara N, Omura T: Contribution of Ad4BP, a steroidogenic cell-specific transcription factor, to regulation of the human CYP11A and bovine CYP11B genes through their distal promoters. J Biochem (Tokyo) 1994, 116:193-203.
192. Morohashi K, Zanger UM, Honda S, Hara M, Waterman MR, Omura T: Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol Endocrinol 1993, 7:1196-204.
193. Lynch JP, Lala DS, Peluso JJ, Luo W, Parker KL, White BA: Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues. Mol Endocrinol 1993, 7:776-86.
194. Young M, McPhaul MJ: A steroidogenic factor-1-binding site and cyclic adenosine 3′,5′-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines. Endocrinology 1998, 139:5082-93.
195. Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH: Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 1997, 272:33068-76.
196. Lopez D, Sandhoff TW, McLean MP: Steroidogenic factor-1 mediates cyclic 3′,5′-adenosine monophosphate regulation of the high density lipoprotein receptor. Endocrinology 1999, 140:3034-44.
197. Lopez D, Nackley AC, W Shea-Eaton, Xue J, Schimmer BP, McLean MP: Effects of mutating different steroidogenic factor-1 protein regions on gene regulation. Endocrine 2001, 14:353-62.
198. Lopez D, Shea-Eaton W, Sanchez MD, McLean MP: DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1. Endocrinology 2001, 142:5097-106.
199. Lopez D, Shea-Eaton W, McLean MP: Characterization of a steroidogenic factor-1-binding site found in promoter of sterol carrier protein-2 gene. Endocrine 2001, 14:253-61.
200. Sugawara T, Kiriakidou M, McAllister JM, Kallen CB, Strauss 3rd JF: Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5′-flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry 1997, 36:7249-55.
201. Sugawara T, Kiriakidou M, McAllister JM, Holt JA, Arakane F, Strauss 3rd JF: Regulation of expression of the steroidogenic acute regulatory protein (StAR) gene: a central role for steroidogenic factor 1. Steroids 1997, 62:5-9.
202. Sugawara T, Saito M, Fujimoto S: Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 2000, 141:2895-903.
203. Brand C, Nury D, Chambaz EM, Feige JJ, Bailly S: Transcriptional regulation of the gene encoding the StAR protein in the human adrenocortical cell line, H295R by cAMP and TGFbeta1. Endocr Res 2000, 26:1045-53.
204. Sandhoff TW, Hales DB, Hales KH, McLean MP: Transcriptional regulation of the rat steroidogenic acute regulatory protein gene by steroidogenic factor 1. Endocrinology 1998, 139:4820-31.
205. Rust W, Stedronsky K, Tillmann G, Morley S, Walther N, Ivell R: The role of SF-1/Ad4BP in the control of the bovine gene for the steroidogenic acute regulatory (StAR) protein. J Mol Endocrinol 1998, 21:189-200.
206. Naville D, Penhoat A, Marchal R, Durand P, Begeot M: SF-1 and the transcriptional regulation of the human ACTH receptor gene. Endocr Res 1998, 24:391-5.
207. Naville D, Penhoat A, Durand P, Begeot M: Three steroidogenic factor-1 binding elements are required for constitutive and cAMP-regulated expression of the human adrenocorticotropin receptor gene. Biochem Biophys Res Commun 1999, 255:28-33.
208. King PJ, Clark AJ: Analysis of the first exon of the murine ACTH receptor gene. Endocr Res 1998, 24:397-402.
209. Heckert LL: Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal E box element. Mol Endocrinol 2001, 15:704-15.
210. Chen S, Shi H, Liu X, Segaloff DL: Multiple elements and protein factors coordinate the basal and cyclic adenosine 3′,5′-monophosphate-induced transcription of the lutropin receptor gene in rat granulosa cells. Endocrinology 1999, 140:2100-9.
211. Duval DL, Nelson SE, Clay CM: A binding site for steroidogenic factor-1 is part of a complex enhancer that mediates expression of the murine gonadotropin-releasing hormone receptor gene. Biol Reprod 1997, 56:160-8.
212. Duval DL, Nelson SE, Clay CM: The tripartite basal enhancer of the gonadotropin-releasing hormone (GnRH) receptor gene promoter regulates cell-specific expression through a novel GnRH receptor activating sequence. Mol Endocrinol 1997, 11:1814-21.
213. Dorn C, Ou Q, Svaren J, Crawford PA, Sadovsky Y: Activation of luteinizing hormone beta gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1. J Biol Chem 1999, 274:13870-6.
214. Halvorson LM, Kaiser UB, Chin WW: The protein kinase C system acts through the early growth response protein 1 to increase LHbeta gene expression in synergy with steroidogenic factor-1. Mol Endocrinol 1999, 13:106-16.
215. Fowkes RC, King P, Burrin JM: Regulation of human glycoprotein hormone alpha-subunit gene transcription in LbetaT2 gonadotropes by protein kinase C and extracellular signal-regulated kinase 1/2. Biol Reprod 2002, 67:725-34.
216. Wehrenberg U, Ivell R, Jansen M, von Goedecke S, Walther N: Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc Natl Acad Sci U S A 1994, 91:1440-4.
217. Wehrenberg U, von Goedecke S, Ivell R, Walther N: The orphan receptor SF-1 binds to the COUP-like element in the promoter of the actively transcribed oxytocin gene. J Neuroendocrinol 1994, 6:1-4.
218. Hu Z, Zhuang L, Guan X, Meng J, Dufau ML: Steroidogenic factor-1 is an essential transcriptional activator for gonad-specific expression of promoter I of the rat prolactin receptor gene. J Biol Chem 1997, 272:14263-71.
219. Burris TP, Guo W, Le T, McCabe ER: Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter. Biochem Biophys Res Commun 1995, 214:576-81.
220. Vilain E, Guo W, Zhang YH, McCabe ER: DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line. Biochem Mol Med 1997, 61:1-8.
221. Yu RN, Ito M, Jameson JL: The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element. Mol Endocrinol 1998, 12:1010-22.
222. Sewer MB, Nguyen VQ, Huang CJ, Tucker PW, Kagawa N, Waterman MR: Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription. Endocrinology 2002, 143:1280-90.
223. Gurates B, Sebastian S, Yang S, Zhou J, Tamura M, Fang Z, Suzuki T, Sasano H, Bulun SE: WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. J Clin Endocrinol Metab 2002, 87:4369-77.